Navigation Links
Business Guru Michael E. Gerber appointed to ReliantHeart Board of Directors
Date:11/21/2013

HOUSTON, TX (PRWEB) November 21, 2013

ReliantHeart, Inc., the manufacturer of the HeartAssist5® Ventricular Assist Device (VAD) has appointed to its Board of Directors Michael E. Gerber, writer of the best-selling book 'The E-Myth Revisited' and well-known legend of entrepreneurship.

INC. Magazine called Gerber “the World’s #1 Business Guru,” with his 40 years of experience addressing the needs of businesses owned primarily by people with technical skills but few business skills, and no place to go to get meaningful help. Over the years, Gerber’s companies have helped tens of thousands of business owners successfully transform their businesses into world-class operations.

Gerber created The Dreaming Room®, a training program that is held throughout the United States, Canada and the United Kingdom. Based on his experiences with entrepreneurs in these Dreaming Room events, along with the tens of thousands of clients Gerber has done business coaching with over the years, he authored 'Awakening the Entrepreneur Within.'

Gerber is also the best-selling author of 'The E-Myth Revisited,' co-authored several E-Myth industry-specific books, and 13 other business coaching books. The 'E-Myth Revisited,' has sold more than 5 million copies in 29 languages, and E-Myth methodology is taught in 118 universities worldwide.

According to Gerber, the core of the E-Myth is to work on the business, not in the business, in order to create the systems that allow ordinary people to produce extraordinary results, over and over again. The systems then allow the business to be continually improved through innovation, quantification and orchestration.

Gerber’s experience will contribute significantly to the ReliantHeart Board of Directors, as the company advances its revolutionary HeartAssist5® VAD, a powerful, implantable, electric pump designed to augment a failing human heart.

The HeartAssist5® has been proven effective in supporting blood circulation, reversing end-organ dysfunction and giving patients a much-improved quality of life as they await heart transplants. More than 12,000 patients worldwide have been supported by ventricular assist devices while awaiting transplant, however, the HeartAssist5® is the only VAD in the world that allows healthcare providers to monitor their patients remotely.

The HeartAssist5® System is currently being implanted in certified centers across Europe. ReliantHeart intends to enter a United States FDA approved clinical trial in 2014 to collect safety and effectiveness data. For more information, visit http://www.ReliantHeart.com.

Read the full story at http://www.prweb.com/releases/2013/11/prweb11356777.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. Dr. Alice Jacobs, CEO of IntelligentMDx, Named Best Entrepreneur in Eighth Annual Stevie® Awards for Women in Business
2. Introducing a New, Easy Way for Industrial Businesses to Join the Online Conversation
3. Amsterdam Molecular Therapeutics Provides Business Update for the Third Quarter 2011
4. McGladrey Manufacturing and Distribution Monitor® Shows Business Accelerating Despite Concerns About Government Gridlock
5. AFFiRiS AG Invests Into Human Capital - Chief Business Officer Recruited
6. Zyngenia, Inc. Promotes Chief Scientific Officer and Hires Chief Business Officer
7. Animal Husbandry Equipment Market in United States: Business Report 2011
8. BioStorage Technologies Mike Reffeitt Named "CFO of the Year" by Indianapolis Business Journal
9. InterMune to Report Unaudited Fourth Quarter Esbriet® Revenue and Business Update on January 5
10. inVentiv Health to Acquire SDI Promotional and Medical Audit Businesses From IMS Health
11. ConnectBiotech.org Launched, a Unique Life Science Business Networking Site
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/24/2017)... -- According to a new market research ... (CD34, PBMC, BLT)), Application (Neuroscience, Hematopoiesis, Oncology, Immunology & ... CRO) - Global Forecast to 2021", published by MarketsandMarkets, ... for the forecast period of 2016 to 2021. This ... 2021 from USD 73.3 Million in 2016, growing at ...
(Date:1/24/2017)... - BioAmber Inc. (NYSE: BIOA ) today announced ... Rodman & Renshaw, a unit of H.C. Wainwright ... representative of several underwriters, under which the underwriters have ... minimum of 2,105,264 shares of common stock of the ... 1,052,632 shares of common stock of the Company with ...
(Date:1/23/2017)... 23, 2017   Enteris BioPharma, Inc. , announced ... Sanofi to leverage Enteris, proprietary and patented ... develop an oral formulation of one of Sanofi,s preclinical ... Chief Executive Officer and Executive Chairman of Enteris BioPharma, ... the tremendous value our Peptelligence platform program offers in ...
(Date:1/23/2017)... , ... January 23, 2017 , ... ... been appointed Vice President, Preclinical Safety and Senior Director, Safety Pharmacology. Dr. ... in India. , Dr. Thomas’ career as an academic and industry preclinical ...
Breaking Biology Technology:
(Date:12/20/2016)... 2016 The rising popularity of mobility ... is stoking significant interest in keyless access systems. ... low energy (BLE), biometrics and near-field communication (NFC) ... of wireless technologies in the automotive industry. This ... access systems opens the market to specialist companies ...
(Date:12/19/2016)... y TORONTO , 19 de diciembre de 2016 ... Inc. que permitirá el desarrollo acelerado de MSC-1, un anticuerpo humanizado ... tipos de tumor en 2017, con múltiples sitios previstos a lo ... ... objetivo en el factor inhibidor de leucemia (LIF), una citoquina pleiotrópica ...
(Date:12/16/2016)... 16, 2016 Research and Markets has announced ... Global Forecast to 2021" report to their offering. ... The biometric vehicle access ... a CAGR of 14.06% from 2016 to 2021. The market is ... to reach 854.8 Million by 2021. The growth of the biometric ...
Breaking Biology News(10 mins):